ExosomePlus develops a liquid biopsy platform that can diagnose with

higher accuracy than conventional diagnosis using exosomes in body

fluid. We strive for early diagnosis and disease recurrence monitoring.

1. We possess exosome isolation technology in body fluid

2. We hold exosome based prostate cancer diagnosis technology 

3. We have more than 10 years experience in exosome research

We will be a company that offers a platform to diagnose 11 major cancers using exosomes in body fluids